SCHEMBL6535328

SCHEMBL6535328

CC(=O)Oc1ccccc1S(C)(=O)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 8/20 0.52
KDM4E B2RXH2 3/20 0.52
HSD17B10 Q99714 2/20 0.52
ALDH1A1 P00352 2/20 0.52
BLM P54132 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
ESR1 P03372 1/20 0.52
ITGB3 P05106 1/20 0.52
ITGA2B P08514 1/20 0.52
HMGB1 P09429 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
GGT1 P19440 1/20 0.52
PTGS1 P23219 1/20 0.52
NAPRT Q6XQN6 1/20 0.52
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
PGAM1 P18669 1/20 0.45
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14655863 0.98 PTGS2 (0.50) PTGS2KDM4EHSD17B10ALDH1A1BLM
SCHEMBL14655825 0.98 PTGS2 (0.50) PTGS2KDM4EHSD17B10ALDH1A1BLM
SCHEMBL9035196 0.86 ADRA2A (0.40) PTGS2KDM4EHSD17B10ALDH1A1BLM
SCHEMBL29753992 0.85 PTGS2 (0.52) PTGS2KDM4EHSD17B10ALDH1A1BLM
SCHEMBL3018679 0.85 PTGS2 (0.52) PTGS2KDM4EHSD17B10ALDH1A1BLM
SCHEMBL11199429 0.83 BCAT2 (0.40) LMNACYP1A2CYP2C9BCAT2KMT2A
SCHEMBL11043927 0.83 PTGS2 (0.50) PTGS2KDM4EHSD17B10ALDH1A1BLM
SCHEMBL8380237 0.83 PTGS2 (0.50) PTGS2KDM4EHSD17B10ALDH1A1BLM
SCHEMBL8380233 0.83 PTGS2 (0.50) PTGS2KDM4EHSD17B10ALDH1A1BLM
SCHEMBL7257591 0.83 PTGS2 (0.50) PTGS2KDM4EHSD17B10ALDH1A1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2551265-B2 Novel process for the preparation of 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of etoricoxib. F I S - FABBRICA ITALIANA SINTETICI S P A (IT) 2017-09-13 EP disclosed
EP-2551265-B1 Novel process for the preparation of 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of etoricoxib. ITALIANA SINT SPA (IT) 2015-01-07 EP disclosed
EP-2551265-A1 Novel process for the preparation of 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of etoricoxib. F.I.S.- Fabbrica Italiana Sintetici S.p.A. (IT) 2013-01-30 EP disclosed
EP-0958275-A4 SELECTIVE INHIBITORS OF PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 UNIV VANDERBILT (US) 2004-12-01 EP disclosed
EP-0958275-A1 SELECTIVE INHIBITORS OF PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 VANDERBILT UNIVERSITY (US) 1999-11-24 EP disclosed
WO-1998029382-A1 SELECTIVE INHIBITORS OF PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 VANDERBILT UNIVERSITY (US) 1998-07-09 WO disclosed